Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Wendy L, St Peter"'
Autor:
Arun Kumar, Pamela L. Lutsey, Wendy L. St. Peter, Jon C. Schommer, Jeremy R. Van’t Hof, Abhijeet Rajpurohit, Joel F. Farley
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 10, Pp 1886-1897 (2023)
Abstract P2Y12 inhibitors (i.e., clopidogrel, prasugrel, or ticagrelor) are effective at reducing adverse cardiovascular outcomes post‐revascularization in coronary artery disease (CAD). However, the choice of a specific P2Y12 inhibitor may vary ac
Externí odkaz:
https://doaj.org/article/e002a9f3ca84407dbaaec17fcc20257e
Publikováno v:
Kidney Medicine, Vol 5, Iss 1, Pp 100564- (2023)
Rationale & Objective: Information regarding disparities in initiating sodium/glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA) in patients with chronic kidney disease (CKD) is limited. We examined so
Externí odkaz:
https://doaj.org/article/7c3ec53b95f94562b4df26b17c87140e
Publikováno v:
Kidney Medicine, Vol 4, Iss 8, Pp 100510- (2022)
Rationale & Objective: Information on safety issues of newer glucose-lowering medications from a large population perspective in chronic kidney disease (CKD) patients with type 2 diabetes is limited. Our study aimed to examine hypoglycemia risk assoc
Externí odkaz:
https://doaj.org/article/02d242b52008481fa9d9c79031f07675
Publikováno v:
Health Science Reports, Vol 5, Iss 4, Pp n/a-n/a (2022)
Abstract Background and Aims Reduced estimated glomerular filtration rate (eGFR
Externí odkaz:
https://doaj.org/article/7086a9903b334fa4b09805e8859b805d
Autor:
Rasheeda K. Hall, Sarah Morton, Jonathan Wilson, Patti L. Ephraim, L. Ebony Boulware, Wendy L. St. Peter, Cathleen Colón-Emeric, Jane Pendergast, Julia J. Scialla
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background and objectives After dialysis initiation, older adults may experience orthostatic or post-dialysis hypotension. Some orthostasis-causing antihypertensives (i.e., central alpha agonists and alpha blockers), are considered potential
Externí odkaz:
https://doaj.org/article/fec9556edf534dd1a3d2e1316c36d050
Autor:
John Wigneswaran, Wendy L. St. Peter, Allen R. Nissenson, Mahesh Krishnan, Richard Faris, Bryan Becker, Jonathan Lorch
Publikováno v:
Kidney Medicine, Vol 1, Iss 5, Pp 307-314 (2019)
Patients with end-stage renal disease treated with dialysis are often prescribed complex medication regimens, placing them at risk for drug-drug interactions and other medication-related problems. Particularly in the context of a broader interest in
Externí odkaz:
https://doaj.org/article/e9396eacbc014be08686e3768c3fdd0b
Autor:
Sirikan Rojanasarot, Angeline M. Carlson, Wendy L. St. Peter, Pinar Karaca-Mandic, Julian Wolfson, Jon C. Schommer
Publikováno v:
Journal of Primary Care & Community Health, Vol 12 (2021)
Introduction/Objectives: Enhancing Care for Patients with Asthma (ECPA), a year-long provider-focused, multi-state, multi-clinic quality improvement program, decreased avoidable utilizations among patients with asthma, but its effects on health care
Externí odkaz:
https://doaj.org/article/2ed5f4a618c741de8245d56eb951fade
Publikováno v:
Kidney Medicine, Vol 3, Iss 2, Pp 173-182.e1 (2021)
Background: Information regarding the use of glucose-lowering medications in patients with chronic kidney disease (CKD) is limited. Study Design: Retrospective cohort study. Setting & Participants: Medicare 5% random sample of patients with CKD with
Externí odkaz:
https://doaj.org/article/3e6a6fe6021b47b2a237902bb31dd804
Autor:
Wendy L. St. Peter, Haifeng Guo, Shaum Kabadi, David T. Gilbertson, Yi Peng, Trudy Pendergraft, Suying Li
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Anemia is common in non-dialysis-dependent chronic kidney disease (NDD-CKD) patients, but detailed information on prevalence and treatment is lacking. Methods We evaluated anemia prevalence and treatment using two datasets: the Me
Externí odkaz:
https://doaj.org/article/563e09127296481fb0cebf1d09a8203e
Autor:
Arun Kumar, Pamela L. Lutsey, Wendy L. St. Peter, Jon C. Schommer, Jeremy R. Van't Hof, Abhijeet Rajpurohit, Joel F. Farley
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:412-422
In closely monitored randomized controlled trials (RCTs), newer P2Y12 agents (ticagrelor and prasugrel) reduced cardiovascular outcomes compared to clopidogrel following percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS). Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17cc9e6c7589fd4737b6bdc8d64ac2f9
https://doi.org/10.1002/cpt.2806
https://doi.org/10.1002/cpt.2806